280 related articles for article (PubMed ID: 20843937)
1. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.
Djulbegovic M; Beyth RJ; Neuberger MM; Stoffs TL; Vieweg J; Djulbegovic B; Dahm P
BMJ; 2010 Sep; 341():c4543. PubMed ID: 20843937
[TBL] [Abstract][Full Text] [Related]
2. Screening for prostate cancer.
Ilic D; O'Connor D; Green S; Wilt T
Cochrane Database Syst Rev; 2006 Jul; (3):CD004720. PubMed ID: 16856057
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.
Ilic D; Djulbegovic M; Jung JH; Hwang EC; Zhou Q; Cleves A; Agoritsas T; Dahm P
BMJ; 2018 Sep; 362():k3519. PubMed ID: 30185521
[TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer: an updated Cochrane systematic review.
Ilic D; O'Connor D; Green S; Wilt TJ
BJU Int; 2011 Mar; 107(6):882-91. PubMed ID: 21392207
[TBL] [Abstract][Full Text] [Related]
5. Screening for prostate cancer: a Cochrane systematic review.
Ilic D; O'Connor D; Green S; Wilt T
Cancer Causes Control; 2007 Apr; 18(3):279-85. PubMed ID: 17206534
[TBL] [Abstract][Full Text] [Related]
6. The Japanese guideline for prostate cancer screening.
Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
[TBL] [Abstract][Full Text] [Related]
7. Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.
Naji L; Randhawa H; Sohani Z; Dennis B; Lautenbach D; Kavanagh O; Bawor M; Banfield L; Profetto J
Ann Fam Med; 2018 Mar; 16(2):149-154. PubMed ID: 29531107
[TBL] [Abstract][Full Text] [Related]
8. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.
Lin K; Lipsitz R; Miller T; Janakiraman S;
Ann Intern Med; 2008 Aug; 149(3):192-9. PubMed ID: 18678846
[TBL] [Abstract][Full Text] [Related]
9. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.
Hayes JH; Barry MJ
JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604
[TBL] [Abstract][Full Text] [Related]
10. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract][Full Text] [Related]
11. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
Carter HB
BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
[TBL] [Abstract][Full Text] [Related]
12. Is prostate-specific antigen effective for population screening of prostate cancer? A systematic review.
Lee YJ; Park JE; Jeon BR; Lee SM; Kim SY; Lee YK
Ann Lab Med; 2013 Jul; 33(4):233-41. PubMed ID: 23826558
[TBL] [Abstract][Full Text] [Related]
13. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
Lim LS; Sherin K;
Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
[TBL] [Abstract][Full Text] [Related]
14. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
16. [Screening and prevention of prostate cancer].
Roosen A
MMW Fortschr Med; 2010 May; 152(19):37-9. PubMed ID: 20557000
[No Abstract] [Full Text] [Related]
17. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]